01 6GILEAD SCIENCES INC
01 68921341
01 6Y
01 6Y
01 62032-11-16
Patent Expiration Date : 2032-11-16
SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
US Patent Number : 8921341
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 209195
Patent Use Code : U-2039
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-11-16
Patent Expiration Date : 2032-11-16
US Patent Number : 8921341
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 208341
Patent Use Code : U-1470
Delist Requested :
Patent Use Description : FOR THE TREATMENT OF H...
Patent Expiration Date : 2032-11-16
Patent Expiration Date : 2032-11-16
US Patent Number : 8921341
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 214187
Patent Use Code : U-1470
Delist Requested :
Patent Use Description : FOR THE TREATMENT OF H...
Patent Expiration Date : 2032-11-16
Patent Expiration Date : 2032-11-16
SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
US Patent Number : 8921341
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 209195
Patent Use Code : U-2040
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-11-16
Patent Expiration Date : 2032-11-16
US Patent Number : 8921341
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 214187
Patent Use Code : U-1470
Delist Requested :
Patent Use Description : FOR THE TREATMENT OF H...
Patent Expiration Date : 2032-11-16
Patent Expiration Date : 2032-11-16
US Patent Number : 8921341
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 208341
Patent Use Code : U-1470
Delist Requested :
Patent Use Description : FOR THE TREATMENT OF H...
Patent Expiration Date : 2032-11-16
